Clinical Trials in Cleveland

Showing 6901-6920 of 15,050 trials

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

NCT02811783

This multi-center, double-blind, vehicle-controlled, randomized crossover design study will evaluate the safety and efficacy of topically applied naloxone lotion, 0.5%, for the treatment of pruritus in patients with the mycosis fungoides (MF) or Sézary syndrome (SS) Forms of Cutaneous T-cell Lymphoma (CTCL). This study will also determine if there is systemic absorption of the drug in a subset of subjects and if so, describe the range and mean plasma levels reached after two weeks of three time daily (TID) dosing. Funding Source - FDA OOPD

Mycosis FungoidesLymphoma, T-Cell, CutaneousSézary Syndrome

Elorac, Inc.59 participantsStarted Jan 2017

Little Rock, Arkansas, United States • Duarte, California, United States • Palo Alto, California, United States +13 more locations

COMPLETEDPhase 1/2< 1 mile

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

NCT03770000

To characterize safety, tolerability and to establish the maximum tolerated dose (MTD) of Tenalisib in combination with Romidepsin in patients with R/R T-cell lymphoma.

T Cell Lymphoma

Rhizen Pharmaceuticals SA33 participantsStarted Mar 2019

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +12 more locations

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

Find Trials by Condition in Cleveland

Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy

Treatments Against RA and Effect on FDG-PET/CT

Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

The Smart Pump Study

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

Study of Dapivirine Vaginal Ring (VR) in Adolescents

Blepharospasm Patient Survey for Patients With Blepharospasm

Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa

Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease

P3 (Prepared, Protected, emPowered)

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

Safety and Efficacy of Sofwave Treatment to Lift Lax Skin

MyLeukoMAP™ Genomic Survival Prediction Assay Pivotal Clinical Study

A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD